Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5-hydroxymethylation Signatures in Plasma Circulating Cell-free DNA as Markers for Tumor Burden and Recurrence in Appendiceal and Colorectal Peritoneal Metastasis

NCT04157322 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04157322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04157322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5-hydroxymethylation Signatures in Plasma Circulating Cell-free DNA as Markers for Tumor Burden and Recurrence in Appendiceal and Colorectal Peritoneal Metastasis
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Active, not recruiting
Start date
August 26, 2019
Completion date
October 31, 2027
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendix cancer, colorectal cancer metastatic, colorectal cancer stage iv, colorectal cancer, genetics of